JAK2 and pulmonary fibrosis: We also investigated one of the main inflammatory pathways induced by pulmonary fibrosis such as the JAK2/STAT3 pathway, to evaluate a possible mechanism of action underlying the beneficial effects of KYP-2047 on pulmonary fibrosis.